Pfizer and Allergan scrap $160 billion 'inversion' deal: Reuters

U.S. drugmaker Pfizer Inc and Ireland-based Allergan Plc formally announced that they were scrapping their $160 billion merger, marking a big win for President Barack Obama who has been pushing to curb tax-slashing "inversion" deals, Reuters News reported.

DealsNorth AmericaUSBriefs